Phase II trial of bevacizumab in combination with docetaxel in women with advanced breast cancer

Clin Breast Cancer. 2003 Oct;4(4):292-4. doi: 10.3816/cbc.2003.n.035.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bevacizumab
  • Breast Neoplasms / drug therapy*
  • Docetaxel
  • Female
  • Humans
  • Taxoids / administration & dosage
  • Taxoids / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Taxoids
  • Docetaxel
  • Bevacizumab